These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38650925)

  • 21. Improvement of the antibody-dependent respiratory burst assay for assessing protective immune responses to malaria.
    Mansourou A; Joos C; Niass O; Diouf B; Tall A; Perraut R; Niang M; Toure-Balde A
    Open Biol; 2022 Mar; 12(3):210288. PubMed ID: 35291880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of crude Plasmodium falciparum antigens for comparison of antibody responses in patients with mild malaria vs. cerebral malaria.
    Mbengue B; Niang B; Diatta B; Tall A; Garraud O; Perraut R; Dieye A
    Iran J Immunol; 2010 Sep; 7(3):150-61. PubMed ID: 20876986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytophilic Antibodies Against Key Plasmodium falciparum Blood Stage Antigens Contribute to Protection Against Clinical Malaria in a High Transmission Region of Eastern India.
    Kana IH; Garcia-Senosiain A; Singh SK; Tiendrebeogo RW; Chourasia BK; Malhotra P; Sharma SK; Das MK; Singh S; Adu B; Theisen M
    J Infect Dis; 2018 Aug; 218(6):956-965. PubMed ID: 29733355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
    de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
    Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
    Roussilhon C; Oeuvray C; Müller-Graf C; Tall A; Rogier C; Trape JF; Theisen M; Balde A; Pérignon JL; Druilhe P
    PLoS Med; 2007 Nov; 4(11):e320. PubMed ID: 18001147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.
    Osier FH; Polley SD; Mwangi T; Lowe B; Conway DJ; Marsh K
    Parasite Immunol; 2007 Aug; 29(8):387-94. PubMed ID: 17650180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of antibody responses to the conserved Plasmodium falciparum merozoite surface protein 5 with protection against clinical malaria.
    Perraut R; Joos C; Sokhna C; Polson HE; Trape JF; Tall A; Marrama L; Mercereau-Puijalon O; Richard V; Longacre S
    PLoS One; 2014; 9(7):e101737. PubMed ID: 25047634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
    Reddy SB; Anders RF; Beeson JG; Färnert A; Kironde F; Berenzon SK; Wahlgren M; Linse S; Persson KE
    PLoS One; 2012; 7(2):e32242. PubMed ID: 22363818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
    Ibison F; Olotu A; Muema DM; Mwacharo J; Ohuma E; Kimani D; Marsh K; Bejon P; Ndungu FM
    PLoS One; 2012; 7(12):e52939. PubMed ID: 23300828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travelers.
    Ndungu FM; Lundblom K; Rono J; Illingworth J; Eriksson S; Färnert A
    Eur J Immunol; 2013 Nov; 43(11):2919-29. PubMed ID: 23881859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.
    Roeffen W; Geeraedts F; Eling W; Beckers P; Wizel B; Kumar N; Lensen T; Sauerwein R
    Infect Immun; 1995 Feb; 63(2):467-71. PubMed ID: 7822011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing neutralization of Plasmodium falciparum using a novel monoclonal antibody against the rhoptry-associated membrane antigen.
    Knudsen AS; Walker MR; Agullet JP; Björnsson KH; Bassi MR; Barfod L
    Sci Rep; 2022 Feb; 12(1):3040. PubMed ID: 35197516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Framework for Characterizing Longitudinal Antibody Response in Children After
    Rogier E; Nace D; Dimbu PR; Wakeman B; Pohl J; Beeson JG; Drakeley C; Tetteh K; Plucinski M
    Front Immunol; 2021; 12():617951. PubMed ID: 33737926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure.
    Yman V; White MT; Asghar M; Sundling C; Sondén K; Draper SJ; Osier FHA; Färnert A
    BMC Med; 2019 Jan; 17(1):22. PubMed ID: 30696449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG opsonization of merozoites: multiple immune mechanisms for malaria vaccine development.
    Hill DL; Schofield L; Wilson DW
    Int J Parasitol; 2017 Sep; 47(10-11):585-595. PubMed ID: 28668325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV infection drives IgM and IgG3 subclass bias in Plasmodium falciparum-specific and total immunoglobulin concentration in Western Kenya.
    Odhiambo EO; Datta D; Guyah B; Ayodo G; Ondigo BN; Abong'o BO; John CC; Frosch AEP
    Malar J; 2019 Aug; 18(1):297. PubMed ID: 31470903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
    Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
    J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children.
    Irani V; Ramsland PA; Guy AJ; Siba PM; Mueller I; Richards JS; Beeson JG
    Clin Infect Dis; 2015 Oct; 61(8):1244-52. PubMed ID: 26136391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.